Artificial Heart
Artificial Heart
IS IT ADVICABLE
WHY WE NEED ARTIFICIAL HEART? IS IT LIFE LONG?
Heart Disease
Heart attack: blockage of coronary artery damages portion of heart muscle Congestive heart failure: gradual weakening of heart Millions suffer from heart disease
Many cases are treatable with lifestyle changes, drugs and/or surgery Surviving patients suffering from most severe cases need new hearts!
Valve opens and closes to control fluid motion to the left and right.
When the fluid moves to the right, blood gets pumped to the lungs through an artificial ventricle. When the fluid moves to the left, blood gets pumped to the rest of the body.
6
Surgical Procedure
1. Implant controller, battery and coil 2. Connect patient to heart-lung machine 3. Cut away ventricles 4. Sew grafts onto atria and arteries 5. Connect implants to grafts 6. Remove patient from heartlung machine
We bring life to engineering!
The Jarvik-7 has two pumps, much like the heart's ventricles. The ventricles are pneumatically (air) powered.
The Jarvik 2000 is an axial flow blood pump. An analog system controller controls the pump speed (8000-12000rpm). Audible and visual alerts notify the user of any problems.
9
or
biventricular
(both
ventricles)
It was the first heart assist device approved by the U.S. Food and Drug
Design Refinement
Process is iterative
You need to repeat various steps after testing Make design changes based on test results
Failed designs
Identify Problem
Specify Criteria
Implement Design
Test Design
Refine Design
The balloon is guided into the descending aorta, approximately 2 cm from the left subclavian artery.
At the start of diastole, the balloon inflates, augmenting coronary perfusion. At the beginning of systole, the balloon deflates.
12
LVAD are used in patients with severe heart failure when the heart is no longer capable of pumping blood.
Inserted in the chest cavity. LVAD moves blood from the left ventricle to the aorta and back through an air driven pump. Reduces the workload of the heart allowing the heart to recover its strength. Currently used for short-term applications.
13
Novel mathematical models of hemolysis and blood coagulation from the viewpoint of nanoscale bio-fluid mechanics will be proposed. The use of VFP, a treatment of multiple organ failure by the blood flow distribution is being established.
VFP Advantages Generating the stable oscillated flow Self-priming function Excellent controllability of the liquid flow Decreasing the hemolysis by the use of jellyfish valve
14
A. There are not enough real hearts donated, so artificial hearts could replace them.
F. Artificial heart transplants can give a patient an extra month or up to 5 years extra life. E. The heart battery needs recharging twice a day, otherwise the heart will stop.
D. Artificial hearts cost between 50,000 and 100, 000 each to make and look after.